We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+2.48%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$14.8B
AUM Growth
+$810M
Cap. Flow
+$560M
Cap. Flow %
3.78%
Top 10 Hldgs %
51.83%
Holding
58
New
8
Increased
21
Reduced
12
Closed
9

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$313M
2
LOW icon
Lowe's Companies
LOW
+$288M
3
AAPL icon
Apple
AAPL
+$281M
4
IQV icon
IQVIA
IQV
+$272M
5
ABBV icon
AbbVie
ABBV
+$188M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$613M
2
PARA
Paramount Global Class B
PARA
+$497M
3
IMS
IMS HEALTH HLDGS INC COM STK (DE)
IMS
+$233M
4
DD
Du Pont De Nemours E I
DD
+$122M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$100M

Sector Composition

Rank Sector Weight
1 Healthcare 51.72%
2 Communication Services 10.85%
3 Materials 8.65%
4 Technology 6.45%
5 Financials 5.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCA icon
1
HCA Healthcare
HCA
$86.4B
$1.35B 9.1%
18,181,441
+2,192,451
+14% +$164M
HUM icon
2
Humana
HUM
$43.8B
$1.29B 8.71%
6,313,790
-3,215,385
-34% -$613M
ELV icon
3
Elevance Health
ELV
$82.7B
$845M 5.71%
5,874,049
+276,807
+5% +$37.1M
CI icon
4
Cigna
CI
$72.8B
$755M 5.11%
5,662,086
-329,310
-5% -$43.1M
AET
5
DELISTED
Aetna Inc
AET
$644M 4.35%
5,194,064
+14,348
+0.3% +$1.72M
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$4.61T
$605M 4.09%
15,272,100
+7,835,120
+105% +$313M
ABBV icon
7
AbbVie
ABBV
$431B
$571M 3.86%
9,116,969
+3,086,828
+51% +$188M
FMC icon
8
FMC
FMC
$1.31B
$540M 3.65%
11,008,634
-1,000,466
-8% -$45.7M
LH icon
9
Labcorp
LH
$25.1B
$538M 3.64%
4,875,135
-27,663
-0.6% -$3.07M
FLEX icon
10
Flex
FLEX
$47.3B
$534M 3.61%
49,325,372
-2,388,600
-5% -$25.5M
IQV icon
11
IQVIA
IQV
$37.5B
$527M 3.56%
6,927,335
+3,545,713
+105% +$272M
TMO icon
12
Thermo Fisher Scientific
TMO
$210B
$516M 3.49%
3,659,734
+973,418
+36% +$144M
CSC
13
DELISTED
Computer Sciences
CSC
$514M 3.48%
8,655,256
+1,013,409
+13% +$58.6M
DD icon
14
DuPont de Nemours
DD
$19B
$503M 3.4%
3,474,197
+1,143,931
+49% +$159M
AAPL icon
15
Apple
AAPL
$4.5T
$365M 2.47%
12,612,380
+9,895,528
+364% +$281M
PARA
16
DELISTED
Paramount Global Class B
PARA
$326M 2.21%
5,128,539
-8,371,888
-62% -$497M
CAR icon
17
Avis
CAR
$4.96B
$304M 2.06%
8,298,004
– –
EHC icon
18
Encompass Health
EHC
$11B
$300M 2.03%
9,138,113
+125,700
+1% +$4.08M
LOW icon
19
Lowe's Companies
LOW
$122B
$290M 1.96%
+4,076,119
New +$288M
THC icon
20
Tenet Healthcare
THC
$20.2B
$265M 1.79%
17,890,230
– –
WMB icon
21
Williams Companies
WMB
$88.5B
$263M 1.78%
8,439,958
+1,400
+0% +$42.2K
LBTYA icon
22
Liberty Global Class A
LBTYA
$3.68B
$239M 1.62%
7,820,359
+3,533,708
+82% +$112M
CHTR icon
23
Charter Communications
CHTR
$17.8B
$222M 1.5%
772,597
+100,000
+15% +$26.9M
BKD icon
24
Brookdale Senior Living
BKD
$3.43B
$207M 1.4%
16,630,415
– –
FDC
25
DELISTED
First Data Corporation
FDC
$192M 1.3%
13,547,383
+2,009,754
+17% +$28.6M
1
2 3

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

Glenview Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Glenview Capital Management held 58 positions worth $14.8B, up 5.8% from $14B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Glenview Capital Management deployed $560M of net new capital in Q4 2016, opening 8 new positions and adding to 21 existing holdings. Its largest new stake was Lowe's Companies: 4,076,119 shares worth $290M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 53% a quarter earlier, followed by Communication Services and Materials.

On the sell side, the largest reduction was Humana, an estimated $613M trimmed.

  • Glenview Capital Management's largest Q4 2016 buy was Lowe's Companies: 4,076,119 shares worth $290M.
  • Glenview Capital Management added most to Alphabet (Google) Class A in Q4 2016, an estimated $313M increase.
  • Glenview Capital Management's biggest Q4 2016 reduction was Humana, cutting an estimated $613M.
  • Glenview Capital Management fully exited IMS HEALTH HLDGS INC COM STK (DE) in Q4 2016, selling an estimated $233M.
  • Glenview Capital Management's ten largest holdings make up 52% of its $14.8B portfolio in Q4 2016.
  • Glenview Capital Management opened 8 new positions and closed 9 in Q4 2016.
  • Glenview Capital Management's portfolio value rose 5.8% quarter-over-quarter to $14.8B.

Based on Glenview Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.